Clinical Trials Logo

Filter by:
NCT ID: NCT00496769 Completed - Atrial Fibrillation Clinical Trials

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

AVERROES
Start date: August 31, 2007
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to determine whether apixaban is more effective than acetylsalicylic acid in the prevention of strokes associated with patients with atrial fibrillation. The safety of this treatment will also be studied.

NCT ID: NCT00496418 Completed - Hernia Clinical Trials

Peristomal Mesh for Prophylaxis of Parastomal Hernia

Start date: July 2007
Phase: Phase 3
Study type: Interventional

The study aims to prove differences or equalities in outcome for patients operated with or without a peristomal mesh in the sublay position when establishing a permanent colostomy.

NCT ID: NCT00496171 Terminated - Healthy Clinical Trials

Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.

NCT ID: NCT00496067 Terminated - Uterine Fibroids Clinical Trials

Uterine Artery Occlusion for Fibroid Related Bleeding

Start date: April 2007
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the safety and effectiveness of Doppler guided Uterine Artery Occlusion (D-UAO) as treatment for the reduction of fibroid-associated symptoms.

NCT ID: NCT00496028 Completed - Neoplasms Clinical Trials

Phase I Study in Patients With Solid Tumours

Start date: March 2007
Phase: Phase 1
Study type: Interventional

This study will comprise 2 parts, a dose escalation phase and a dose expansion phase. The 2 phases are part of a single study and described by this single protocol. Patients entered into the dose escalation phase will not be entered into the expansion phase. All subjects must be suitable for treatment with either carboplatin and/or paclitaxel.

NCT ID: NCT00495248 Active, not recruiting - Stroke Clinical Trials

Thriving, Activity and Social Participation After Stroke

Start date: January 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of the study is to evaluate the effect of a group intervention programme for community dwelling elders with stroke or TIA.The intervention is inspired by a Lifestyle Redesign method developed in the USA. The study is conducted as a multi centre randomized controlled trial. Participants are recruited from five hospitals and the intervention is implemented at six to seven senior centres. The control group is offered physical activity at the senior centre once a week. The intervention group is offered the same with addition of the programme inspired by Lifestyle Redesign. The study will contribute to knowledge whether the intervention will promote social participation and thriving in daily life and prevent social isolation and depressive symptoms among community dwelling elders with stroke or TIA.

NCT ID: NCT00493298 Completed - Clinical trials for Relapsing-Remitting Multiple Sclerosis

Tysabri Observational Program

TOP
Start date: June 29, 2007
Phase:
Study type: Observational

The primary objective of this study is to assess the long-term safety and impact on disease activity and progression of Tysabri in participants with relapsing remitting multiple sclerosis (RRMS) in a clinical practice setting.

NCT ID: NCT00492635 Completed - Clinical trials for Erectile Dysfunction

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Start date: December 2004
Phase: Phase 3
Study type: Interventional

A study to assess the efficacy of vardenafil, taken as a tablet both nightly or 'as needed' (immediately before intended sexual activity) compared to placebo, to evaluate its tolerability and if it can help in recovery of erections after a nerve sparing radical prostatectomy.

NCT ID: NCT00491920 Completed - Osteoporosis Clinical Trials

High Dosage Vitamin D and Osteoporosis

Start date: February 2007
Phase: Phase 4
Study type: Interventional

Vitamin D and calcium are essential in the treatment and prevention of osteoporosis. What dosage of vitamin D which is the ideal one, is not yet clear. We want to test the hypothesis that high dosage of vitamin D (i.e. 6500 IU/d) is better than standard dosage (800 IU/d) in a randomized double-blind trial. We will include 400 postmenopausal otherwise healthy women with T-score <= -2.0 in L2-4 or mean total hip. Everybody will receive calcium 1000 mg and vitamin D 800 IU every day. Half of the group will also receive vitamin D 40 000 IU/week, while the other half will have placebo. The study period is one year.

NCT ID: NCT00491829 Completed - Clinical trials for Sexual Dysfunctions, Psychological

Flibanserin Versus Placebo in Premenopausal Women With HSDD

Start date: June 2007
Phase: Phase 3
Study type: Interventional

To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in 6-month treatment, vs placebo for Hypoactive Sexual Desire Disorder in premenopausal European women. To evaluate safety and tolerability of flibanserin in such patients.